Global Opthalmology Drugs and Devices Market Insights, Forecast to 2031

Report ID: 1667257 | Published Date: Dec 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Opthalmology Drugs and Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Device
        1.2.3 Drug
    1.3 Market by Application
        1.3.1 Global Opthalmology Drugs and Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hosptial
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Opthalmology Drugs and Devices Market Perspective (2017-2028)
    2.2 Opthalmology Drugs and Devices Growth Trends by Region
        2.2.1 Opthalmology Drugs and Devices Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Opthalmology Drugs and Devices Historic Market Size by Region (2017-2022)
        2.2.3 Opthalmology Drugs and Devices Forecasted Market Size by Region (2023-2028)
    2.3 Opthalmology Drugs and Devices Market Dynamics
        2.3.1 Opthalmology Drugs and Devices Industry Trends
        2.3.2 Opthalmology Drugs and Devices Market Drivers
        2.3.3 Opthalmology Drugs and Devices Market Challenges
        2.3.4 Opthalmology Drugs and Devices Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Opthalmology Drugs and Devices Players by Revenue
        3.1.1 Global Top Opthalmology Drugs and Devices Players by Revenue (2017-2022)
        3.1.2 Global Opthalmology Drugs and Devices Revenue Market Share by Players (2017-2022)
    3.2 Global Opthalmology Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Opthalmology Drugs and Devices Revenue
    3.4 Global Opthalmology Drugs and Devices Market Concentration Ratio
        3.4.1 Global Opthalmology Drugs and Devices Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Opthalmology Drugs and Devices Revenue in 2021
    3.5 Opthalmology Drugs and Devices Key Players Head office and Area Served
    3.6 Key Players Opthalmology Drugs and Devices Product Solution and Service
    3.7 Date of Enter into Opthalmology Drugs and Devices Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Opthalmology Drugs and Devices Breakdown Data by Type
    4.1 Global Opthalmology Drugs and Devices Historic Market Size by Type (2017-2022)
    4.2 Global Opthalmology Drugs and Devices Forecasted Market Size by Type (2023-2028)
5 Opthalmology Drugs and Devices Breakdown Data by Application
    5.1 Global Opthalmology Drugs and Devices Historic Market Size by Application (2017-2022)
    5.2 Global Opthalmology Drugs and Devices Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Opthalmology Drugs and Devices Market Size (2017-2028)
    6.2 North America Opthalmology Drugs and Devices Market Size by Type
        6.2.1 North America Opthalmology Drugs and Devices Market Size by Type (2017-2022)
        6.2.2 North America Opthalmology Drugs and Devices Market Size by Type (2023-2028)
        6.2.3 North America Opthalmology Drugs and Devices Market Share by Type (2017-2028)
    6.3 North America Opthalmology Drugs and Devices Market Size by Application
        6.3.1 North America Opthalmology Drugs and Devices Market Size by Application (2017-2022)
        6.3.2 North America Opthalmology Drugs and Devices Market Size by Application (2023-2028)
        6.3.3 North America Opthalmology Drugs and Devices Market Share by Application (2017-2028)
    6.4 North America Opthalmology Drugs and Devices Market Size by Country
        6.4.1 North America Opthalmology Drugs and Devices Market Size by Country (2017-2022)
        6.4.2 North America Opthalmology Drugs and Devices Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Opthalmology Drugs and Devices Market Size (2017-2028)
    7.2 Europe Opthalmology Drugs and Devices Market Size by Type
        7.2.1 Europe Opthalmology Drugs and Devices Market Size by Type (2017-2022)
        7.2.2 Europe Opthalmology Drugs and Devices Market Size by Type (2023-2028)
        7.2.3 Europe Opthalmology Drugs and Devices Market Share by Type (2017-2028)
    7.3 Europe Opthalmology Drugs and Devices Market Size by Application
        7.3.1 Europe Opthalmology Drugs and Devices Market Size by Application (2017-2022)
        7.3.2 Europe Opthalmology Drugs and Devices Market Size by Application (2023-2028)
        7.3.3 Europe Opthalmology Drugs and Devices Market Share by Application (2017-2028)
    7.4 Europe Opthalmology Drugs and Devices Market Size by Country
        7.4.1 Europe Opthalmology Drugs and Devices Market Size by Country (2017-2022)
        7.4.2 Europe Opthalmology Drugs and Devices Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Opthalmology Drugs and Devices Market Size (2017-2028)
    8.2 Asia-Pacific Opthalmology Drugs and Devices Market Size by Type
        8.2.1 Asia-Pacific Opthalmology Drugs and Devices Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Opthalmology Drugs and Devices Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Opthalmology Drugs and Devices Market Share by Type (2017-2028)
    8.3 Asia-Pacific Opthalmology Drugs and Devices Market Size by Application
        8.3.1 Asia-Pacific Opthalmology Drugs and Devices Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Opthalmology Drugs and Devices Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Opthalmology Drugs and Devices Market Share by Application (2017-2028)
    8.4 Asia-Pacific Opthalmology Drugs and Devices Market Size by Region
        8.4.1 Asia-Pacific Opthalmology Drugs and Devices Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Opthalmology Drugs and Devices Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Opthalmology Drugs and Devices Market Size (2017-2028)
    9.2 Latin America Opthalmology Drugs and Devices Market Size by Type
        9.2.1 Latin America Opthalmology Drugs and Devices Market Size by Type (2017-2022)
        9.2.2 Latin America Opthalmology Drugs and Devices Market Size by Type (2023-2028)
        9.2.3 Latin America Opthalmology Drugs and Devices Market Share by Type (2017-2028)
    9.3 Latin America Opthalmology Drugs and Devices Market Size by Application
        9.3.1 Latin America Opthalmology Drugs and Devices Market Size by Application (2017-2022)
        9.3.2 Latin America Opthalmology Drugs and Devices Market Size by Application (2023-2028)
        9.3.3 Latin America Opthalmology Drugs and Devices Market Share by Application (2017-2028)
    9.4 Latin America Opthalmology Drugs and Devices Market Size by Country
        9.4.1 Latin America Opthalmology Drugs and Devices Market Size by Country (2017-2022)
        9.4.2 Latin America Opthalmology Drugs and Devices Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Opthalmology Drugs and Devices Market Size (2017-2028)
    10.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Type
        10.2.1 Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Opthalmology Drugs and Devices Market Share by Type (2017-2028)
    10.3 Middle East & Africa Opthalmology Drugs and Devices Market Size by Application
        10.3.1 Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Opthalmology Drugs and Devices Market Share by Application (2017-2028)
    10.4 Middle East & Africa Opthalmology Drugs and Devices Market Size by Country
        10.4.1 Middle East & Africa Opthalmology Drugs and Devices Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Opthalmology Drugs and Devices Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Merck (US)
        11.1.1 Merck (US) Company Details
        11.1.2 Merck (US) Business Overview
        11.1.3 Merck (US) Opthalmology Drugs and Devices Introduction
        11.1.4 Merck (US) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.1.5 Merck (US) Recent Developments
    11.2 Pfizer (US)
        11.2.1 Pfizer (US) Company Details
        11.2.2 Pfizer (US) Business Overview
        11.2.3 Pfizer (US) Opthalmology Drugs and Devices Introduction
        11.2.4 Pfizer (US) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.2.5 Pfizer (US) Recent Developments
    11.3 Roche Holdings (Switzerland)
        11.3.1 Roche Holdings (Switzerland) Company Details
        11.3.2 Roche Holdings (Switzerland) Business Overview
        11.3.3 Roche Holdings (Switzerland) Opthalmology Drugs and Devices Introduction
        11.3.4 Roche Holdings (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.3.5 Roche Holdings (Switzerland) Recent Developments
    11.4 Santen Pharmaceutical(Japan)
        11.4.1 Santen Pharmaceutical(Japan) Company Details
        11.4.2 Santen Pharmaceutical(Japan) Business Overview
        11.4.3 Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Introduction
        11.4.4 Santen Pharmaceutical(Japan) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.4.5 Santen Pharmaceutical(Japan) Recent Developments
    11.5 Alcon (Switzerland)
        11.5.1 Alcon (Switzerland) Company Details
        11.5.2 Alcon (Switzerland) Business Overview
        11.5.3 Alcon (Switzerland) Opthalmology Drugs and Devices Introduction
        11.5.4 Alcon (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.5.5 Alcon (Switzerland) Recent Developments
    11.6 Bausch & Lomb (US)
        11.6.1 Bausch & Lomb (US) Company Details
        11.6.2 Bausch & Lomb (US) Business Overview
        11.6.3 Bausch & Lomb (US) Opthalmology Drugs and Devices Introduction
        11.6.4 Bausch & Lomb (US) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.6.5 Bausch & Lomb (US) Recent Developments
    11.7 Carl Zeiss Meditec (Germany)
        11.7.1 Carl Zeiss Meditec (Germany) Company Details
        11.7.2 Carl Zeiss Meditec (Germany) Business Overview
        11.7.3 Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Introduction
        11.7.4 Carl Zeiss Meditec (Germany) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.7.5 Carl Zeiss Meditec (Germany) Recent Developments
    11.8 Essilor International S.A. (France)
        11.8.1 Essilor International S.A. (France) Company Details
        11.8.2 Essilor International S.A. (France) Business Overview
        11.8.3 Essilor International S.A. (France) Opthalmology Drugs and Devices Introduction
        11.8.4 Essilor International S.A. (France) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.8.5 Essilor International S.A. (France) Recent Developments
    11.9 Johnson & Johnson (US)
        11.9.1 Johnson & Johnson (US) Company Details
        11.9.2 Johnson & Johnson (US) Business Overview
        11.9.3 Johnson & Johnson (US) Opthalmology Drugs and Devices Introduction
        11.9.4 Johnson & Johnson (US) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.9.5 Johnson & Johnson (US) Recent Developments
    11.10 Nidek(Japan)
        11.10.1 Nidek(Japan) Company Details
        11.10.2 Nidek(Japan) Business Overview
        11.10.3 Nidek(Japan) Opthalmology Drugs and Devices Introduction
        11.10.4 Nidek(Japan) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.10.5 Nidek(Japan) Recent Developments
    11.11 Topcon Corporation (Japan)
        11.11.1 Topcon Corporation (Japan) Company Details
        11.11.2 Topcon Corporation (Japan) Business Overview
        11.11.3 Topcon Corporation (Japan) Opthalmology Drugs and Devices Introduction
        11.11.4 Topcon Corporation (Japan) Revenue in Opthalmology Drugs and Devices Business (2017-2022)
        11.11.5 Topcon Corporation (Japan) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Opthalmology Drugs and Devices Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Device
    Table 3. Key Players of Drug
    Table 4. Global Opthalmology Drugs and Devices Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Opthalmology Drugs and Devices Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Opthalmology Drugs and Devices Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Opthalmology Drugs and Devices Market Share by Region (2017-2022)
    Table 8. Global Opthalmology Drugs and Devices Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Opthalmology Drugs and Devices Market Share by Region (2023-2028)
    Table 10. Opthalmology Drugs and Devices Market Trends
    Table 11. Opthalmology Drugs and Devices Market Drivers
    Table 12. Opthalmology Drugs and Devices Market Challenges
    Table 13. Opthalmology Drugs and Devices Market Restraints
    Table 14. Global Opthalmology Drugs and Devices Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Opthalmology Drugs and Devices Revenue Share by Players (2017-2022)
    Table 16. Global Top Opthalmology Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opthalmology Drugs and Devices as of 2021)
    Table 17. Ranking of Global Top Opthalmology Drugs and Devices Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Opthalmology Drugs and Devices Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Opthalmology Drugs and Devices Product Solution and Service
    Table 21. Date of Enter into Opthalmology Drugs and Devices Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Opthalmology Drugs and Devices Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Opthalmology Drugs and Devices Revenue Market Share by Type (2017-2022)
    Table 25. Global Opthalmology Drugs and Devices Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Opthalmology Drugs and Devices Revenue Market Share by Type (2023-2028)
    Table 27. Global Opthalmology Drugs and Devices Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Opthalmology Drugs and Devices Revenue Share by Application (2017-2022)
    Table 29. Global Opthalmology Drugs and Devices Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Opthalmology Drugs and Devices Revenue Share by Application (2023-2028)
    Table 31. North America Opthalmology Drugs and Devices Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Opthalmology Drugs and Devices Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Opthalmology Drugs and Devices Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Opthalmology Drugs and Devices Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Opthalmology Drugs and Devices Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Opthalmology Drugs and Devices Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Opthalmology Drugs and Devices Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Opthalmology Drugs and Devices Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Opthalmology Drugs and Devices Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Opthalmology Drugs and Devices Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Opthalmology Drugs and Devices Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Opthalmology Drugs and Devices Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Opthalmology Drugs and Devices Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Opthalmology Drugs and Devices Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Opthalmology Drugs and Devices Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Opthalmology Drugs and Devices Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Opthalmology Drugs and Devices Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Opthalmology Drugs and Devices Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Opthalmology Drugs and Devices Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Opthalmology Drugs and Devices Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Opthalmology Drugs and Devices Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Opthalmology Drugs and Devices Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Opthalmology Drugs and Devices Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Opthalmology Drugs and Devices Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Opthalmology Drugs and Devices Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Opthalmology Drugs and Devices Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Opthalmology Drugs and Devices Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Opthalmology Drugs and Devices Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Opthalmology Drugs and Devices Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Opthalmology Drugs and Devices Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Merck (US) Company Details
    Table 62. Merck (US) Business Overview
    Table 63. Merck (US) Opthalmology Drugs and Devices Product
    Table 64. Merck (US) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 65. Merck (US) Recent Developments
    Table 66. Pfizer (US) Company Details
    Table 67. Pfizer (US) Business Overview
    Table 68. Pfizer (US) Opthalmology Drugs and Devices Product
    Table 69. Pfizer (US) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 70. Pfizer (US) Recent Developments
    Table 71. Roche Holdings (Switzerland) Company Details
    Table 72. Roche Holdings (Switzerland) Business Overview
    Table 73. Roche Holdings (Switzerland) Opthalmology Drugs and Devices Product
    Table 74. Roche Holdings (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 75. Roche Holdings (Switzerland) Recent Developments
    Table 76. Santen Pharmaceutical(Japan) Company Details
    Table 77. Santen Pharmaceutical(Japan) Business Overview
    Table 78. Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Product
    Table 79. Santen Pharmaceutical(Japan) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 80. Santen Pharmaceutical(Japan) Recent Developments
    Table 81. Alcon (Switzerland) Company Details
    Table 82. Alcon (Switzerland) Business Overview
    Table 83. Alcon (Switzerland) Opthalmology Drugs and Devices Product
    Table 84. Alcon (Switzerland) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 85. Alcon (Switzerland) Recent Developments
    Table 86. Bausch & Lomb (US) Company Details
    Table 87. Bausch & Lomb (US) Business Overview
    Table 88. Bausch & Lomb (US) Opthalmology Drugs and Devices Product
    Table 89. Bausch & Lomb (US) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 90. Bausch & Lomb (US) Recent Developments
    Table 91. Carl Zeiss Meditec (Germany) Company Details
    Table 92. Carl Zeiss Meditec (Germany) Business Overview
    Table 93. Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Product
    Table 94. Carl Zeiss Meditec (Germany) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 95. Carl Zeiss Meditec (Germany) Recent Developments
    Table 96. Essilor International S.A. (France) Company Details
    Table 97. Essilor International S.A. (France) Business Overview
    Table 98. Essilor International S.A. (France) Opthalmology Drugs and Devices Product
    Table 99. Essilor International S.A. (France) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 100. Essilor International S.A. (France) Recent Developments
    Table 101. Johnson & Johnson (US) Company Details
    Table 102. Johnson & Johnson (US) Business Overview
    Table 103. Johnson & Johnson (US) Opthalmology Drugs and Devices Product
    Table 104. Johnson & Johnson (US) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 105. Johnson & Johnson (US) Recent Developments
    Table 106. Nidek(Japan) Company Details
    Table 107. Nidek(Japan) Business Overview
    Table 108. Nidek(Japan) Opthalmology Drugs and Devices Product
    Table 109. Nidek(Japan) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 110. Nidek(Japan) Recent Developments
    Table 111. Topcon Corporation (Japan) Company Details
    Table 112. Topcon Corporation (Japan) Business Overview
    Table 113. Topcon Corporation (Japan) Opthalmology Drugs and Devices Product
    Table 114. Topcon Corporation (Japan) Revenue in Opthalmology Drugs and Devices Business (2017-2022) & (US$ Million)
    Table 115. Topcon Corporation (Japan) Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Opthalmology Drugs and Devices Market Share by Type: 2021 VS 2028
    Figure 2. Device Features
    Figure 3. Drug Features
    Figure 4. Global Opthalmology Drugs and Devices Market Share by Application: 2021 VS 2028
    Figure 5. Hosptial Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Others Case Studies
    Figure 8. Opthalmology Drugs and Devices Report Years Considered
    Figure 9. Global Opthalmology Drugs and Devices Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Opthalmology Drugs and Devices Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Opthalmology Drugs and Devices Market Share by Region: 2021 VS 2028
    Figure 12. Global Opthalmology Drugs and Devices Market Share by Players in 2021
    Figure 13. Global Top Opthalmology Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opthalmology Drugs and Devices as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Opthalmology Drugs and Devices Revenue in 2021
    Figure 15. North America Opthalmology Drugs and Devices Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Opthalmology Drugs and Devices Market Size Market Share by Type (2017-2028)
    Figure 17. North America Opthalmology Drugs and Devices Market Size Market Share by Application (2017-2028)
    Figure 18. North America Opthalmology Drugs and Devices Market Size Share by Country (2017-2028)
    Figure 19. United States Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Opthalmology Drugs and Devices Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Opthalmology Drugs and Devices Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Opthalmology Drugs and Devices Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Opthalmology Drugs and Devices Market Size Share by Country (2017-2028)
    Figure 25. Germany Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Opthalmology Drugs and Devices Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Opthalmology Drugs and Devices Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Opthalmology Drugs and Devices Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Opthalmology Drugs and Devices Market Size Share by Region (2017-2028)
    Figure 35. China Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Opthalmology Drugs and Devices Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Opthalmology Drugs and Devices Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Opthalmology Drugs and Devices Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Opthalmology Drugs and Devices Market Size Share by Country (2017-2028)
    Figure 45. Mexico Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Opthalmology Drugs and Devices Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Opthalmology Drugs and Devices Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Opthalmology Drugs and Devices Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Opthalmology Drugs and Devices Market Size Share by Country (2017-2028)
    Figure 51. Turkey Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Opthalmology Drugs and Devices Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Merck (US) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 55. Pfizer (US) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 56. Roche Holdings (Switzerland) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 57. Santen Pharmaceutical(Japan) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 58. Alcon (Switzerland) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 59. Bausch & Lomb (US) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 60. Carl Zeiss Meditec (Germany) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 61. Essilor International S.A. (France) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 62. Johnson & Johnson (US) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 63. Nidek(Japan) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 64. Topcon Corporation (Japan) Revenue Growth Rate in Opthalmology Drugs and Devices Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck (US)
Pfizer (US)
Roche Holdings (Switzerland)
Santen Pharmaceutical(Japan)
Alcon (Switzerland)
Bausch & Lomb (US)
Carl Zeiss Meditec (Germany)
Essilor International S.A. (France)
Johnson & Johnson (US)
Nidek(Japan)
Topcon Corporation (Japan)
Frequently Asked Questions
Opthalmology Drugs and Devices report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Opthalmology Drugs and Devices report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Opthalmology Drugs and Devices report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Orthopedic

Orthopedic market is segmented by players, region (country), by Type and by Application. Players, ... Read More

Polylactic

Polylactic market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More